Targeted Metabolomics Analysis of Bile Acids in Patients with Idiosyncratic Drug-Induced Liver Injury
Open Access
- 8 December 2021
- journal article
- research article
- Published by MDPI AG in Metabolites
- Vol. 11 (12) , 852
Abstract
Drug-induced liver injury (DILI) is rare but clinically important due to a high rate of mortality. However, specific biomarkers for diagnosing and predicting the severity and prognosis of DILI are lacking. Here, we used targeted metabolomics to identify and quantify specific types of bile acids that can predict the severity of DILI. A total of 161 DILI patients were enrolled in this prospective cohort study, as well as 31 health controls. A targeted metabolomics method was used to identify 24 types of bile acids. DILI patients were divided into mild, moderate, and severe groups according to disease severity. A multivariate analysis was performed to identify characteristic bile acids. Then the patients were divided into severe and non-severe groups, and logistic regression was used to identify bile acids that could predict DILI severity. Among the enrolled DILI patients, 32 were in the mild group, 90 were in the moderate group, and 39 were in the severe group. Orthogonal partial least squares-discriminant analysis (OPLS-DA) modeling clearly discriminated among the different groups. Among the four groups, glycochenodeoxycholate (GCDCA), taurochenodeoxycholate (TCDCA), deoxycholic acid (DCA), Nor Cholic acid (NorCA), glycocholic acid (GCA), and taurocholic acid (TCA) showed significant differences in concentration between at least two groups. NorCA, GCDCA, and TCDCA were all independent risk factors that differentiated severe DILI patients from the other groups. The area under the receiver operating characteristic curve (AUROC) of GCDCA, TCDCA, and NorCA was 0.856, 0.792, and 0.753, respectively. Together, these three bile acids had an AUROC of 0.895 for predicting severe DILI patients. DILI patients with different disease severities have specific bile acid metabolomics. NorCA, GCDTA, and TCDCA were independent risk factors for differentiating severe DILI patients from less-severe patients and have the potential to predict DILI severity.Keywords
Funding Information
- Key research and development project of Department of Science and Technology of Zhejiang Province (2017C03051)
- Independent Task of State Key Laboratory for Diagnosis and Treatment of Infectious Diseases (2021)
- National Key Research and Development Program of China (2019YFC0840600, 2019YFC0840609)
This publication has 38 references indexed in Scilit:
- Serum metabolomics reveals γ-glutamyl dipeptides as biomarkers for discrimination among different forms of liver diseaseJournal of Hepatology, 2011
- Case Definition and Phenotype Standardization in Drug-Induced Liver InjuryClinical Pharmacology & Therapeutics, 2011
- Biomarkers for the Diagnosis and Management of Drug-Induced Liver InjurySeminars in Liver Disease, 2009
- Involvement of endoplasmic reticulum in glycochenodeoxycholic acid-induced apoptosis in rat hepatocytesToxicology Letters, 2006
- Drug-induced liver injury: Summary of a single topic clinical research conferenceHepatology, 2006
- The effect of ursodeoxycholic acid on glycochenodeoxycholic acid-induced apoptosis in rat hepatocytesToxicology, 2005
- Phosphatidylinositol 3-kinase-dependent signaling modulates taurochenodeoxycholic acid-induced liver injury and cholestasis in perfused rat liversAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2005
- Causality assessment of adverse reactions to drugs—II. An original model for validation of drug causality assessment methods: Case reports with positive rechallengeJournal of Clinical Epidemiology, 1993
- Bile acid profiles in bile, urine, and feces of a patient with cerebrotendinous xanthomatosisSteroids, 1986
- Unusual trihydroxylated bile acids in urine of patients with liver cirrhosisClinica Chimica Acta, 1983